Emerging role of circular RNAs in the pathogenesis of ovarian cancer.
Biomarker
Expression
Ovarian cancer
circRNA
Journal
Cancer cell international
ISSN: 1475-2867
Titre abrégé: Cancer Cell Int
Pays: England
ID NLM: 101139795
Informations de publication
Date de publication:
29 Apr 2022
29 Apr 2022
Historique:
received:
31
01
2022
accepted:
18
04
2022
entrez:
29
4
2022
pubmed:
30
4
2022
medline:
30
4
2022
Statut:
epublish
Résumé
Ovarian cancer is a female malignancy with high fatality-to-case ratio, which is due to late detection of cancer. Understanding the molecular mechanisms participating in these processes would facilitate design of therapeutic modalities and identification of novel tumor markers. Recent investigations have shown contribution of circular RNAs (circRNAs) in the evolution of ovarian cancer. These transcripts are produced through a back-splicing mechanism. The enclosed configuration of circRNAs protects them from degradation and potentiates them as biomarkers. Several circRNAs such as circMUC16, circRNA_MYLK, circRNA-UBAP2, circWHSC1, hsa_circ_0013958, circFGFR3, hsa_circRNA_102958 and circ_0072995 have been found to be up-regulated in this cancer, acting as oncogenes. On the other hand, circ-ITCH, circPLEKHM3, circ_100395, circ_0078607, circATRNL1, circHIPK3, circRHOBTB3, circEXOC6B, circ9119 and CDR1as are among down-regulated circRNAs in ovarian cancer. Expression levels of circCELSR1, circ_CELSR1, circATL2, circNRIP1, circTNPO3 and hsa_circ_0000714 have been shown to affect resistance of ovarian cancer cells to chemotherapy. Moreover, circ_100395, circFGFR3, circ_0000554, circCELSR1, circ-PTK2, circLNPEP, circ-CSPP1, circ_0000745, circ_100395 and circPLEKHM3 have been shown to regulate epithelial-mesenchymal transition and metastatic ability of ovarian cancer cells. In the current review, we explain the roles of circRNAs in the evolution and progression of ovarian cancer.
Identifiants
pubmed: 35488239
doi: 10.1186/s12935-022-02602-1
pii: 10.1186/s12935-022-02602-1
pmc: PMC9052556
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
172Informations de copyright
© 2022. The Author(s).
Références
Onco Targets Ther. 2019 May 17;12:3869-3879
pubmed: 31190886
J Ovarian Res. 2020 Jul 20;13(1):81
pubmed: 32690086
BMC Cancer. 2019 Jun 11;19(1):565
pubmed: 31185953
J Ovarian Res. 2022 Jan 4;15(1):3
pubmed: 34983607
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1224-1233
pubmed: 30945557
Onco Targets Ther. 2020 Sep 09;13:8963-8976
pubmed: 32982288
Biomed Pharmacother. 2019 Jun;114:108832
pubmed: 30965236
J Ovarian Res. 2021 Nov 13;14(1):154
pubmed: 34774079
Onco Targets Ther. 2019 Nov 14;12:9715-9723
pubmed: 32009804
Biomed Pharmacother. 2021 Aug;140:111721
pubmed: 34015582
J Cell Mol Med. 2019 May;23(5):3597-3602
pubmed: 30887698
Cancer Cell Int. 2020 Jan 06;20:5
pubmed: 31911757
Cancer Biother Radiopharm. 2022 Nov;37(9):802-814
pubmed: 33006481
Mol Ther Nucleic Acids. 2019 Dec 6;18:882-892
pubmed: 31751911
Eur Rev Med Pharmacol Sci. 2019 Sep;23(17):7283-7294
pubmed: 31539115
Cell Death Discov. 2021 Jan 22;7(1):22
pubmed: 33483472
Mol Ther Nucleic Acids. 2018 Dec 7;13:55-63
pubmed: 30236833
Mol Ther Nucleic Acids. 2019 Dec 6;18:24-33
pubmed: 31479922
J Ovarian Res. 2021 Nov 17;14(1):160
pubmed: 34789310
J Ovarian Res. 2021 Nov 16;14(1):158
pubmed: 34784955
Hepatology. 2020 Jul;72(1):365
pubmed: 32380575
J Cell Mol Med. 2019 Dec;23(12):8472-8481
pubmed: 31639291
Front Genet. 2021 Jul 21;12:644451
pubmed: 34367233
Cancer Cell Int. 2020 Jul 23;20:336
pubmed: 32714095
J Ovarian Res. 2020 Jun 5;13(1):64
pubmed: 32503653
Cell Death Dis. 2021 Feb 26;12(2):219
pubmed: 33637694
Mol Med Rep. 2021 May;23(5):
pubmed: 33760208
Onco Targets Ther. 2021 May 13;14:3151-3165
pubmed: 34012271
Aging (Albany NY). 2021 Apr 25;13(8):12058-12066
pubmed: 33896797
Saudi J Biol Sci. 2021 Nov;28(11):6260-6265
pubmed: 34759745
Cell Signal. 2021 Aug;84:110014
pubmed: 33894314
Int J Mol Med. 2021 Feb;47(2):668-676
pubmed: 33416105
Hepatology. 2021 Jun;73(6):2610
pubmed: 33107137
Cell Cycle. 2020 Aug;19(15):1857-1868
pubmed: 32588730
Aging (Albany NY). 2020 Jul 15;12(14):14080-14091
pubmed: 32668414
BMC Cancer. 2022 Jan 3;22(1):6
pubmed: 34980005
Onco Targets Ther. 2020 Aug 19;13:8233-8243
pubmed: 32884301
J Cancer. 2019 Jun 24;10(17):3908-3913
pubmed: 31417634
Drug Dev Res. 2022 Apr;83(2):512-524
pubmed: 34541682
Biochem Biophys Res Commun. 2018 Oct 20;505(1):222-228
pubmed: 30243714
Int J Biochem Cell Biol. 2019 Jul;112:8-17
pubmed: 31026505
BMC Anesthesiol. 2021 Nov 27;21(1):297
pubmed: 34837947
Mol Cancer. 2019 Oct 17;18(1):144
pubmed: 31623606
J Cancer. 2021 Jan 1;12(2):611-621
pubmed: 33391456
Aging (Albany NY). 2020 Oct 7;12(19):19095-19106
pubmed: 33028742
Biosci Rep. 2020 Jul 31;40(7):
pubmed: 32667627
Onco Targets Ther. 2019 Sep 11;12:7451-7457
pubmed: 31686850
Zhonghua Zhong Liu Za Zhi. 2021 Oct 23;43(10):1062-1068
pubmed: 34695896
Aging (Albany NY). 2020 Aug 5;12(18):17921-17929
pubmed: 32979257
Cancer Lett. 2020 Mar 31;473:139-147
pubmed: 31904484
Reprod Sci. 2020 Jan;27(1):375-379
pubmed: 32046413
J Exp Clin Cancer Res. 2019 Oct 30;38(1):437
pubmed: 31666098
Oncol Rep. 2019 Dec;42(6):2728-2737
pubmed: 31638250
J Ovarian Res. 2021 Oct 14;14(1):136
pubmed: 34649611
Onco Targets Ther. 2020 Dec 24;13:13211-13224
pubmed: 33380810
Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3713-3718
pubmed: 29949144
Cancer Med. 2020 Apr;9(7):2491-2499
pubmed: 32023009
Biosci Trends. 2019 May 12;13(2):204-211
pubmed: 31019161
Cancer Biomark. 2018;23(4):505-513
pubmed: 30347599
Cancer Cell Int. 2021 May 25;21(1):277
pubmed: 34034740
Biochem Genet. 2022 Feb;60(1):153-172
pubmed: 34132956
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Anticancer Drugs. 2021 Jun 1;32(5):496-507
pubmed: 33735118
Cancer Manag Res. 2020 Sep 28;12:9159-9171
pubmed: 33061608
Front Cell Dev Biol. 2020 Nov 19;8:595585
pubmed: 33330483
J Cell Biochem. 2019 Dec;120(12):19406-19414
pubmed: 31452245
Eur Rev Med Pharmacol Sci. 2018 Nov;22(21):7178-7182
pubmed: 30468459
J Obstet Gynaecol Res. 2020 Apr;46(4):625-635
pubmed: 32048451
Pathol Res Pract. 2021 Jul;223:153496
pubmed: 34052769
Epigenomics. 2020 Feb;12(3):267-283
pubmed: 31808351
Cancer Biother Radiopharm. 2019 Mar;34(2):110-118
pubmed: 30376358
J BUON. 2021 May-Jun;26(3):691-697
pubmed: 34268922
Eur Rev Med Pharmacol Sci. 2020 Oct;24(20):10375-10382
pubmed: 33155193
Mol Med. 2020 Jul 8;26(1):70
pubmed: 32640974
J Biosci. 2021;46:
pubmed: 33737494
Cancer Cell Int. 2020 Nov 27;20(1):572
pubmed: 33292255
Biochem Biophys Res Commun. 2020 May 21;526(1):14-20
pubmed: 32192774
Panminerva Med. 2020 Jul 27;:
pubmed: 32720791
Mol Ther Nucleic Acids. 2020 Sep 4;21:780-791
pubmed: 32791450
J Ovarian Res. 2021 Sep 10;14(1):118
pubmed: 34507595
J Ovarian Res. 2020 Jan 27;13(1):10
pubmed: 31987036
Pathol Res Pract. 2021 Jan;217:153275
pubmed: 33285422
Cancer Lett. 2021 Sep 28;516:99-100
pubmed: 34126194
Cancer Cell Int. 2021 Jan 6;21(1):11
pubmed: 33407501
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5281-5291
pubmed: 32495861
J Ovarian Res. 2021 Feb 9;14(1):30
pubmed: 33563314
Pathol Res Pract. 2021 Jul;223:153495
pubmed: 34051512
Cancer Biomark. 2019;26(2):151-161
pubmed: 31381507
Mol Cancer. 2020 Feb 28;19(1):45
pubmed: 32111227
Front Biosci (Landmark Ed). 2009 Jan 01;14(6):2089-102
pubmed: 19273186
Onco Targets Ther. 2021 Jan 07;14:97-110
pubmed: 33442269
Am J Transl Res. 2021 Mar 15;13(3):1125-1139
pubmed: 33841644
Cancer Manag Res. 2021 Mar 29;13:2877-2883
pubmed: 33833570
J Gynecol Oncol. 2020 Sep;31(5):e75
pubmed: 32808501
J Cancer. 2020 Jan 1;11(3):599-609
pubmed: 31942183
Cell Transplant. 2020 Jan-Dec;29:963689720943613
pubmed: 32731816
Environ Sci Pollut Res Int. 2022 Mar;29(13):19072-19080
pubmed: 34709546
Aging (Albany NY). 2020 Jul 16;12(14):14314-14328
pubmed: 32675386
Cancer Med. 2020 May;9(10):3500-3521
pubmed: 32167655
Mol Ther Nucleic Acids. 2020 Mar 6;19:718-730
pubmed: 31945729
Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8119-8126
pubmed: 30556849
J Clin Lab Anal. 2020 Jul;34(7):e23292
pubmed: 32157748
Cancer Manag Res. 2020 May 28;12:4045-4053
pubmed: 32547237
Cell Cycle. 2021 Oct;20(19):2021-2039
pubmed: 34465271
Aging (Albany NY). 2020 Sep 2;12(17):17209-17223
pubmed: 32877369
Mol Oncol. 2021 Apr;15(4):1217-1233
pubmed: 33372356
Reprod Biol Endocrinol. 2021 Nov 30;19(1):176
pubmed: 34847936